General Information of Drug (ID: DMH8UF0)

Drug Name
SY-1425 Drug Info
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 1 [1]
Myelodysplastic syndrome 2A37 Phase 1 [1]
Cross-matching ID
PubChem CID
108143
TTD Drug ID
DMH8UF0

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [2]
IRX-5183 DMCED9U Solid tumour/cancer 2A00-2F9Z Phase 1 [3]
PMID27336223-Compound-4 DMJFSOM N. A. N. A. Patented [4]
PMID27336223-Compound-5 DM6E50A N. A. N. A. Patented [4]
LG100268 DM41RK2 Acquired immune deficiency syndrome 1C62.3 Discontinued in Phase 1 [5]
CD666 DMC8X9Y Discovery agent N.A. Investigative [6]
AGN193109 DMC0YOE Discovery agent N.A. Investigative [7]
AGN193836 DMEB93D Discovery agent N.A. Investigative [8]
BMS614 DMZWNO9 Discovery agent N.A. Investigative [9]
Ro-40-0655 DM8PYAN Colorectal cancer 2B91.Z Investigative [10]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Retinoic acid receptor alpha (RARA) TTW38KT RARA_HUMAN Agonist [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Tamibarotene: a candidate retinoid drug for Alzheimer's disease. Biol Pharm Bull. 2012;35(8):1206-12.
3 Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med (Berl). 2004 Feb;82(2):116-25.
4 Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.Expert Opin Ther Pat. 2016 Aug;26(8):957-71.
5 Placental steroidogenesis in rats is independent of signaling pathways induced by retinoic acids. Gen Comp Endocrinol. 2009 Sep 15;163(3):285-91.
6 Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma. Biochem Biophys Res Commun. 1992 Jul 31;186(2):977-83.
7 Therapeutic applications for ligands of retinoid receptors. Curr Pharm Des. 2000 Jan;6(1):25-58.
8 Synthesis and biological activity of retinoic acid receptor-alpha specific amides. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3145-8.
9 Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature. 2002 Jan 10;415(6868):187-92.
10 Tamibarotene. Drugs Today (Barc). 2007 Aug;43(8):563-8.